Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 21, 2021; 27(43): 7509-7529
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7509
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7509
Figure 1 Establishment and validation of CCL4-induced acute liver injury and chronic liver injury in mice.
A: Workflow for the establishment of the acute liver injury (ALI) and chronic liver injury (CLI) mouse models; B: Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in ALI mice. Compared with the ALI control (AC) group, aP < 0.05, bP < 0.01; C: Hematoxylin-eosin (H&E) and Sirius Red staining of liver sections from AC, 2 d and 7 d mice; D: Serum ALT and AST levels in CLI mice. Compared with the CC group, aP < 0.05; E: H&E and Sirius Red staining of liver sections from CLI control (CC), 8 wk and 12 wk mice. Scale bar = 100 μm. D: Day; W: Week.
- Citation: Lv XF, Zhang AQ, Liu WQ, Zhao M, Li J, He L, Cheng L, Sun YF, Qin G, Lu P, Ji YH, Ji JL. Liver injury changes the biological characters of serum small extracellular vesicles and reprograms hepatic macrophages in mice. World J Gastroenterol 2021; 27(43): 7509-7529
- URL: https://www.wjgnet.com/1007-9327/full/v27/i43/7509.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i43.7509